Dosimetric associations between high-dose cardiac exposure and global longitudinal strain deterioration after definitive radiotherapy for lung cancer

Clicks: 1
ID: 323473
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #277 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Radiation-induced cardiac injury is an important late effect of definitive radiotherapy for lung cancer (1). Global longitudinal strain (GLS) is a sensitive marker of subclinical myocardial dysfunction; however, its relationship with detailed cardiac dosimetry remains incompletely defined (2). Purpose To evaluate associations between cardiac dose–volume parameters and GLS deterioration after definitive radiotherapy for non-metastatic lung cancer, and to assess effect modification by hypertension. Methods Patients with non-metastatic lung cancer treated with definitive radiotherapy or concurrent chemoradiotherapy were identified from a prospective registry with protocol-driven echocardiographic follow-up. Cardiac dose–volume parameters for the whole heart and cardiac substructures were derived using a standardized cardiac atlas. GLS change from baseline to follow-up was analyzed using multivariable linear regression adjusted for baseline GLS and established cardiovascular risk factors, with interaction analyses for hypertension. Results Ninety-eight patients with paired baseline and follow-up echocardiography were included. Median GLS significantly deteriorated from −16.17 at baseline to −14.11 at follow-up, corresponding to a median increase of 1.82% (95% CI, 1.40–2.25; p < 0.001) (Figure 1). In adjusted analyses, higher total prescribed dose was significantly associated with GLS deterioration (β = 0.009 per 10 Gy increase, 95% CI 0.001–0.017, p = 0.032). Among cardiac substructures, ventricular high-dose exposure demonstrated the strongest associations with GLS change. Specifically, both left ventricular (LV) and right ventricular (RV) V45 (percentage volume receiving ≥45 Gy) were significantly associated with GLS deterioration (LV V45: β = 0.351 per 10% increase, 95% CI 0.044–0.658, p = 0.026; RV V45: β = 0.840, 95% CI 0.240–1.439, p = 0.007). In contrast, atrial dose parameters were not associated with GLS change. Hypertension significantly modified the association between LV V45 and GLS deterioration. GLS change per 10% increase in LV V45 was modest among patients without hypertension but markedly greater among patients with hypertension, with a significant interaction (p for interaction = 0.027) (Figure 2). During follow-up, 8 patients (8.2%) experienced CVD events, including arrhythmia, heart failure, and pulmonary thromboembolism. Conclusions High-dose ventricular cardiac exposure during definitive radiotherapy for lung cancer is associated with subclinical myocardial dysfunction as measured by GLS, with a disproportionately greater impact among patients with hypertension. These findings support ventricular dose optimization and hypertension-informed cardiac surveillance strategies in lung cancer radiotherapy.Paired change in GLS Association between V45 and GLS
Reference Key
openalex_W7172314074 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors J Jang, K Yang, E Kim, H Pyo
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.134
URL
https://doi.org/10.1093/eurheartjsupp/suag097.134
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.